A need of the hour: pharmacovigilance in healthcare setting – nothing less than safety

Simple item page
dc.creatorShanbhag, Preeti
dc.creatorS, Satish
dc.creatorBhat, Ramdas
dc.creatorA R Shabaraya
dc.date.accessioned2026-01-10T19:04:07Z
dc.date.available2026-01-10T19:04:07Z
dc.date.issued2023-12-10
dc.descriptionIntroduction: Pharmacovigilance (PV) is crucial to identify, managing, and reporting adverse drug reactions (ADRs) in the healthcare sector. Young healthcare professionals (HCPs) play an essential role in the PV system. Objective: This study aimed to assess awareness, understand the causes of underreporting, and find solutions to encourage ADR reporting among young HCPs. Methods: This prevalidated, questionnaire-based, cross-sectional study aimed to evaluate the knowledge, attitude, perception, and strategies to improve PV reporting among 152 young HCP interns at a teaching hospital in India. The study was conducted in January 2023 and approved by the ethics committee. The responses were analysed using a Microsoft Excel worksheet. Results In a study of 152 interns, 97.3% agreed that pharmacovigilance (PV) may assist patients, but only 56% had experienced adverse drug reactions (ADRs) in practise. Only 40.5% chose email reporting, and 65.8% did not have a nearby ADR Monitoring Centre (AMC). More over half (53%) thought ADRs should only be reported to an AMC. Training sessions were underutilised, with only 28.6% attending PVPI training. The difficulty in identifying the causal substance, as well as a lack of incentives, were important reasons for underreporting. Continuing medical education/workshops were mentioned by 96% of young HCPs as a way to encourage reporting. Conclusion: According to the study, while young HCPs are aware of PV, there is a need for more training and incentives to enhance ADR reporting. Encouragement of National Pharmacovigilance Week and the availability of neighbouring AMCs could further aid raise PV awareness. Keywords: Adverse drug reactions (ADR), PVPI, AMC, CMEen-US
dc.formattext/xml
dc.formatapplication/pdf
dc.identifierhttps://sumathipublications.com/index.php/ijcrpp/article/view/470
dc.identifier.urihttps://repos.sumathipublications.com:8000/handle/123456789/263
dc.languageeng
dc.publisherSumathi Publicationsen-US
dc.relationhttps://sumathipublications.com/index.php/ijcrpp/article/view/470/637
dc.relationhttps://sumathipublications.com/index.php/ijcrpp/article/view/470/634
dc.relation.ispartofInternational Journal of Current Research in Physiology and Pharmacologyen-US
dc.relation.ispartofseriesVolume 7, Supplement 3en-US
dc.rightsCopyright (c) 2023 Preeti Shanbhag, Satish S , Mr.Ramdas Bhat, A R Shabarayaen-US
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0en-US
dc.sourceInternational Journal of Current Research in Physiology and Pharmacology; Volume 7, Supplement 3; 2023; 19-24en-US
dc.source2523-6709
dc.source2523-6695
dc.subjectKey words: Adverse drug reactions (ADR), PVPI, AMC, CMEen-US
dc.titleA need of the hour: pharmacovigilance in healthcare setting – nothing less than safetyen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Files

Collections

International Journal of Current Research in Physiology and Pharmacology (IJCRPP)